// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

USE AND REASONS FOR NON-USE OF ANTIMALARIAL DRUGS IN A DUTCH COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

M. W.P. Tsang-A-Sjoe - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EXPANSION OF CD4+CXCR3+ T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CORRELATES WITH SUBCLINICAL ATHEROSCLEROSIS

K. Sacre - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ARTERIAL STIFFNESS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS: A CONTROLLED STUDY

K. Sacre - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

CLINICAL COURSE OF MESANGIAL LUPUS NEPHRITIS IN A COHORT OF ARGENTINIAN PATIENTS

M. Collado - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

LONG TERM OUTCOMES OF CHILDREN BORN TO MOTHERS WITH SLE: PREDICTORS OF CHILD DEVELOPMENT AND INFECTIONS

M. Gayed - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

CHILDREN BORN TO MOTHERS WITH SLE: NO INCREASE IN MALES AND HYDROXYCHLOROQUINE DOES NOT PROTECT AGAINST NEONATAL LUPUS

M. Gayed - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

IMPACT OF FIBROMYALGIA ON PERCEIVED PAIN IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

O. Krausslach - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

SILENT LUPUS NEPHRITIS IN PROTOCOL BIOPSY AFTER COMPLETE REMISSION

P. Moya - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

HYDROXYCHLOROQUINE DOWN-REGULATES INTERFERON-ALFA ELEVATION THROUGH TLR-9 RECOGNITION OF NUCLEOTIDES WHICH IS IRRESPONSIVE TO GLUCOCORTICOID

O. Jin - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

IN VIVO TREATMENT WITH HYDROXICHLOROQUINE INTERFERES WITH EX VIVO EXPANSION OF MESENCHYMAL STROMAL CELLS IN A MURINE MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS

S. Vagnani - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EFFICACY AND SAFETY OF CYCLOSPORINE-A DURING PREGNANCY IN AUTOIMMUNE DISEASES

R. Reggia - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Pregnancy-Induced Hypertension

Hydroxychloroquine

EFFECTS OF VARIOUS IMMUNOSUPPRESSANTS IN THE DISEASE DAMAGE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

S. S. Shaharir - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

THE EFFECT OF HYDROXYCHLOROQUINE TO THE LIPID PROFILE OF GREEK PATIENTS WITH Sjogren's Syndrome

A. A. Drosos - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

Hydroxychloroquine

COMBINATION OF MYCOPHENOLATE MOFETIL AND TACROLIMUS FOR REFRACTORY LUPUS NEPHRITIS: A 12-MONTH OPEN-LABELED TRIAL

C. C. Mok - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Diabetes

Hydroxychloroquine

SAFETY OF HYDROXYCHLOROQUINE IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

G. Hakobyan - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

TREATMENT OF PRIMARY Sjogren's Syndrome-ASSOCIATED LUNG DISEASE: A PROSPECTIVE STUDY

H. Gao - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sjogren's syndrome

Hydroxychloroquine

SYSTEMATIC REVIEW OF DRUG TRIALS IN THE TREATMENT OF GIANT CELL ARTERITIS

M. Yates - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Hydroxychloroquine

CYSTIC FIBROSIS RELATED ARTHRITIS IN ADULTS IN SOUTH EAST ENGLAND

A. Jawad - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Vitamin D deficiency

Hydroxychloroquine

EFFICACY OF RITUXIMAB IN SYSTEMIC MANIFESTATIONS OF PATIENTS WITH PRIMARY Sjogren's Syndrome: RESULTS FROM THE AIR REGISTRY

G. Cinquetti - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

Hydroxychloroquine

TARGETED TREATMENT WITH COMBINATION DMARDS PRODUCES EXCELLENT CLINICAL AND RADIOGRAPHIC LONG-TERM OUTCOMES IN EARLY RHEUMATOID ARTHRITIS REGARDLESS OF INITIAL INFLIXIMAB. THE 5-YEAR FOLLOW-UP RESULTS OF THE NEO-RACO TRIAL

V. Rantalaiho - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved